These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 6573959)

  • 21. Vindesine, prednisone, and daunomycin in acute lymphoblastic leukemia in relapse.
    Garay G; Milone J; Dibar E; Pavlovsky S; Kvicala R; Sackmann Muriel F; Montres Varela D; Eppinger-Helft M
    Cancer Chemother Pharmacol; 1983; 10(3):224-6. PubMed ID: 6345018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase-II trial with vindesine for regression induction in patients with leukemias and hematosarcomas.
    Bayssas M; Gouveia J; Ribaud P; Musset M; de Vassal F; Pico JL; de Luca L; Misset JL; Machover D; Belpomme D; Schwarzenberg L; Jasmin C; Hayat M; Mathé G
    Cancer Chemother Pharmacol; 1979; 2(4):247-55. PubMed ID: 287569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chemotherapy for chronic leukemia].
    Kitajima K; Takahashi I; Fujimoto S
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):1895-902. PubMed ID: 6964033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II trial of vindesine in the treatment of lymphomas, breast cancer, and other solid tumors.
    Miller TP; Jones SE; Chester A
    Cancer Treat Rep; 1980; 64(8-9):1001-3. PubMed ID: 7448818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vindesine in the treatment of refractory hematologic malignancies: a phase II study.
    Mandelli F; Amadori S; Giona F; Antonietta M; Spiriti A; Pastore S; Meloni G; Paolucci G
    Leuk Res; 1982; 6(5):649-52. PubMed ID: 7154707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Two cases of acute myelogenous leukemia with eosinophilia which progressed into complete remission with the treatment mainly consisting of vindesine and prednisolone].
    Yamada O; Naohara T; Aoyama M; Totsuka K; Muto K; Ito N; Otani T; Oshimi K; Mizoguchi H; Okada M
    Rinsho Ketsueki; 1983 Jan; 24(1):45-50. PubMed ID: 6573521
    [No Abstract]   [Full Text] [Related]  

  • 28. A phase II trail of vindesine in patients with refractory small-cell carcinoma of the lung.
    Fuks JZ; Aisner J; Carney DN; Van Echo DA; Ostrow SS; Ihde DC; Wiernik PH
    Am J Clin Oncol; 1982 Feb; 5(1):49-52. PubMed ID: 6282108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Daunorubicin-prednisone in the treatment of acute nonlymphocytic leukemia.
    Peterson BA; Bloomfield CD; Theologides A; Kennedy BJ
    Cancer Treat Rep; 1981; 65 Suppl 4():29-33. PubMed ID: 6955011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of vinorelbine, epirubicin and prednisone combination regimen in pretreated elderly patients with aggressive non-Hodgkin's lymphoma.
    Zinzani PL; Tani M; Stefoni V; Albertini P; Bendandi M; Gherlinzoni F; Alinari L; Vigna E; Tura S
    Haematologica; 2001 Mar; 86(3):287-90. PubMed ID: 11255276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Vindesine and adriamycin in the therapy of metastatic breast cancer].
    Wander HE; Nagel GA
    Onkologie; 1982 Aug; 5 Suppl():5-7. PubMed ID: 6752792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of bestatin on patients with acute and chronic leukemia and malignant lymphoma.
    Arimori S; Nagao T; Shimizu Y; Watanabe K; Komatsuda M
    Tokai J Exp Clin Med; 1980 Jan; 5(1):63-71. PubMed ID: 6930119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advanced diffuse histiocytic lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) without maintenance therapy.
    Armitage JO; Corder MP; Leimert JT; Dick FR; Elliot TE
    Cancer Treat Rep; 1980; 64(4-5):649-54. PubMed ID: 7000347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isophosphamide therapy for hematologic malignancies in patients refractory to prior treatment.
    Rodriguez V; McCredie KB; Keating MJ; Valdivieso M; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1978 Apr; 62(4):493-7. PubMed ID: 350386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Acute leukemias and solid tumors in the course of Hodgkin disease].
    Jacquillat C; Auclerc G; Weil M; Auclerc MF; Maral J
    Bull Cancer; 1983; 70(1):61-6. PubMed ID: 6687694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vindesine and prednisone for remission induction in children with acute lymphocytic leukemia.
    Vats TS; Mehta P; Trueworthy RC; Smith SD; Klopovich P
    Cancer; 1981 Jun; 47(12):2789-92. PubMed ID: 6942907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Phase II study of mitoxantrone for hematologic malignancies].
    Ueoka H; Ueno K; Yamane T; Toyoda K; Endo H; Nishihara R; Takahashi I; Ohnoshi T; Kitajima K; Kimura I
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2399-402. PubMed ID: 6639101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Initial clinical studies of vindesine.
    Valdivieso M; Richman S; Burgess AM; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1981; 65(9-10):873-5. PubMed ID: 6268296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytogenetic studies of patients suffering from leukemia and treated with "Velbe".
    Krajincanić B; Grujevski G; Radojicić B; Lazarov A
    Strahlentherapie; 1974 Dec; 148(6):614-8. PubMed ID: 4532342
    [No Abstract]   [Full Text] [Related]  

  • 40. Broad phase II study of vindesine.
    Valdivieso M; Bedikian AY; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1981; 65(9-10):877-9. PubMed ID: 7273021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.